GSK-3484862 targets DNMT1 for degradation in cells.
Chen Q, Liu B, Zeng Y, Hwang JW, Dai N, Corrêa IR Jr, Estecio MR, Zhang X, Santos MA, Chen T, Cheng X.
Chen Q, et al. Among authors: cheng x.
NAR Cancer. 2023 May 17;5(2):zcad022. doi: 10.1093/narcan/zcad022. eCollection 2023 Jun.
NAR Cancer. 2023.
PMID: 37206360
Free PMC article.